PETER MAANAO: Open Payments
NPI 1154026425 · CARMICHAEL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,106 in 55 payments from 13 companies in 2025. Trend: 2023 $163 · 2024 $388 · 2025 $1,106
Food & beverage: $1,106
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $344 |
| Neurocrine BioSciences, Inc. | 6 | $221 |
| PFIZER INC. | 13 | $196 |
| Teva Pharmaceuticals USA, Inc. | 4 | $85 |
| Amgen Inc. | 2 | $54 |
| ARGENX US, INC. | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| AppliedVR Inc | 1 | $22 |
| Philips North America LLC | 1 | $21 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
Products named: INGREZZA, NURTEC ODT, QULIPTA, UBRELVY, AUSTEDO XR, UPLIZNA, HYQVIA, VYVGART HYTRULO.
Industry payments across CA — which companies pay providers there.
